Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10XB-101 (Polidocanol) Safety Study for Submental Fat
NCT04258761Phase 2Completed
- Sponsor
- 10xBio
- Start
- Oct 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 10XB101 in submental fat, sponsored by 10xBio. Started Oct 2019; status: completed.
02
Drugs
10XB101
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT04258761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04258761.